Vertrix Wealth Management LLC Acquires Shares of 2,929 Cencora, Inc. $COR

Vertrix Wealth Management LLC acquired a new stake in Cencora, Inc. (NYSE:COR) during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 2,929 shares of the company’s stock, valued at approximately $920,000.

A number of other hedge funds also recently modified their holdings of COR. Kemnay Advisory Services Inc. acquired a new position in Cencora in the 4th quarter valued at about $25,000. Oakworth Capital Inc. acquired a new stake in Cencora during the fourth quarter worth approximately $26,000. Elyxium Wealth LLC acquired a new stake in Cencora during the fourth quarter worth approximately $27,000. Archer Investment Corp boosted its holdings in shares of Cencora by 134.3% during the fourth quarter. Archer Investment Corp now owns 82 shares of the company’s stock worth $28,000 after acquiring an additional 47 shares during the period. Finally, Motiv8 Investments LLC acquired a new position in shares of Cencora in the fourth quarter valued at approximately $29,000. Institutional investors and hedge funds own 97.52% of the company’s stock.

Cencora Price Performance

Shares of NYSE COR opened at $288.20 on Thursday. The stock has a market capitalization of $56.07 billion, a PE ratio of 22.10, a P/E/G ratio of 1.57 and a beta of 0.58. The company has a debt-to-equity ratio of 3.40, a current ratio of 0.95 and a quick ratio of 0.59. The business has a fifty day moving average price of $278.46 and a two-hundred day moving average price of $320.89. Cencora, Inc. has a fifty-two week low of $244.82 and a fifty-two week high of $377.54.

Cencora (NYSE:COR) last released its earnings results on Wednesday, May 6th. The company reported $4.75 earnings per share for the quarter, missing analysts’ consensus estimates of $4.82 by ($0.07). Cencora had a net margin of 0.78% and a return on equity of 135.20%. The company had revenue of $78.36 billion for the quarter, compared to the consensus estimate of $81.09 billion. During the same quarter in the previous year, the company posted $4.42 earnings per share. The business’s revenue was up 3.9% compared to the same quarter last year. Cencora has set its FY 2026 guidance at 17.650-17.900 EPS. As a group, equities analysts predict that Cencora, Inc. will post 17.79 earnings per share for the current fiscal year.

Cencora Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Monday, June 1st. Shareholders of record on Friday, May 15th were paid a dividend of $0.60 per share. This represents a $2.40 dividend on an annualized basis and a yield of 0.8%. The ex-dividend date was Friday, May 15th. Cencora’s dividend payout ratio is presently 18.40%.

Cencora announced that its board has initiated a stock buyback program on Thursday, May 21st that permits the company to buyback $2.00 billion in outstanding shares. This buyback authorization permits the company to reacquire up to 3.9% of its stock through open market purchases. Stock buyback programs are often a sign that the company’s management believes its stock is undervalued.

Analyst Upgrades and Downgrades

A number of equities analysts have recently weighed in on the company. Robert W. Baird lowered their target price on Cencora from $420.00 to $339.00 and set an “outperform” rating on the stock in a research note on Thursday, May 7th. UBS Group upped their price objective on Cencora from $410.00 to $412.00 and gave the company a “buy” rating in a report on Thursday, May 7th. William Blair began coverage on Cencora in a report on Tuesday, April 28th. They set a “market perform” rating for the company. Morgan Stanley set a $342.00 price target on shares of Cencora in a research note on Friday, May 8th. Finally, Evercore set a $360.00 price target on shares of Cencora in a research report on Wednesday, April 8th. Eleven research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $367.75.

Insider Transactions at Cencora

In other news, Director Lauren M. Tyler bought 550 shares of the firm’s stock in a transaction on Monday, June 22nd. The shares were purchased at an average cost of $270.23 per share, with a total value of $148,626.50. Following the acquisition, the director directly owned 4,359 shares in the company, valued at $1,177,932.57. This represents a 14.44% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 0.38% of the stock is owned by insiders.

Cencora Company Profile

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.